Topics
Ocular Oncology Updates 2011
Steroids for the Treatment of Diabetic Macular Edema
Supported by an educational grant from Alimera Sciences.
View Supplement
Innovations in Retina
Diabetic Eye Care
Supported by an unrestricted educational grant from Genentech
Intraoperative Imaging and Visualization for Vitreoretinal Surgery
New Research for Retina Disease
This continuing medical education activity is supported by an unrestricted educational grant from Allergan, Inc.
New Frontiers in Diabetic Macular Edema
Stellaris PC: An Advanced Solution to Combined Surgery
Sponsored by Bausch + Lomb
View Insert
Injection Techniques for the Dexamethasone Intravitreal Implant
Sponsored by Allergan
Closed System and Expanded Instrumentation Improves MIVS Outcomes
Sponsored by Alcon Laboratories, Inc.
Symptomatic Vitreomacular Adhesion
This continuing medical education activity is supported by an unrestricted educational grant from ThromboGenics
Retinal Vein Occlusion
Emerging Data on New Therapies and Treatment Paradigms for RVO Treatment
New Insights on the Management of AMD
New Developments in Drug Delivery & Endurance
Retina Surgery 2011: In Pursuit of Improved Outcomes
Evaluating and Integrating New Evidence in the Treatment of Diabetic Macular Edema
Provided by the Annenberg Center for Health Sciences at Eisenhower
Free Print Subscription
Email Newsletter
Conference Calendar
June 24, 2026
Kalaris to Present Phase 1a Data on VEGF/HSPG Biologic at ASRS 2026
Ollin Biosciences Raises $330 Million to Advance Phase 3 Development of VEGF/Ang2 bispecific Antibody
June 23, 2026
Oculgen Announces First US Patient Enrolled in STAT Trial of OCUL101 for Wet AMD
June 22, 2026
Atsena Doses First Patient in Phase 3 LIGHTHOUSE Trial of Gene Therapy for XLRS